Our studies uncovered a novel link between NFE2L3 and colitis 39 associated tumorigenesis, showing that loss of Nfe2l3 leads to a decrease in mast cell recruitment, inflammation and tumorigenesis coupled with an increase in the presence of immunosuppressive Tregs. This evidence concerns the gene NFE2L3 and colitis.